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Purpose: To develop and validate an accurate, sensitive and reproducible high performance liquid 
chromatographic (HPLC) method for the quantitation of vitamin C in pharmaceutical samples. 
Method: The drug and the standard were eluted from Superspher RP-18 (250 mm x 4.6 mm, 10µm 
particle size) at 20 
0
C. The mobile phase was prepared by carefully adding acetic acid (500 ml) to 1.5g 
of 1-hexanesulfonic acid sodium salt  and  mixing well (pH 2.6). The flow rate was 0.7 mL min
-1
. UV 
detector, set at 280 nm, was used to monitor the effluent. 
Results: Each analysis required no longer than 4 min. The limit of quantitation was 1.95 µg mL
-1
. 
Recovery (%) for different concentrations ranged from 99.58 to 101.93. 
Conclusion: The simplicity of this low-cost, rapid technique and its high specificity to ascorbic acid, 
even in the presence of a variety of excipients, demonstrate that this HPLC method would be particularly 
suitable for the determination of ascorbic acid in the investigated preparations as well as other similar 
pharmaceutical/veterinary formulations without prior sample preparation. 
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INTRODUCTION 
 
Vitamin C (ascorbic acid, ascorbate, AA) is a 
water-soluble organic compound involved in 
many biological processes [1]. Although all 
the functions of AA have not been fully 
elucidated, it is likely that it is also involved in 
maintaining the reduced state of metal 
cofactors, for example, monooxygenase 
(Cu
+
) and dioxygenase (Fe
2+
). In cells, the 
other role of AA is to reduce hydrogen 
peroxide (H2O2), which preserves cells 
against reactive oxygen species [2]. Primates 
and several other mammals are not able to 
synthesis ascorbic acid. The only way 
humans can obtain ascorbic acid is via food, 
but the exact daily requirements of vitamin C 
for humans are not yet clear. Currently, the 
estimated average requirement and 
recommended dietary allowance of ascorbic 
acid are 100 and 120 mg per day, 
respectively [3]. 
 
Many analytical techniques including sensors 
and biosensors [4-6] have been suggested 
for the detection of ascorbic acid in various 
types of samples. Integrated methods, 
utilizing flow injection analysis, high 
performance liquid chromatography [7-9] or 
capillary electrophoresis [10-13] and a 
detector, are mostly employed for the 
determination of vitamin C. However, some of 
these methods are time-consuming, while 
others are costly, require special training for 
operators of the equipment, or suffer from 
insufficient sensitivity or selectivity.  
  
Vitamin C has been widely employed in 
pharmaceutical and cosmetic preparations to 
protect them against oxidation and to exert 
physiological/biological activities.  In view of 
the fact that pharmaceutical dosage forms 
usually contain a variety of excipients that 
may appear as interferents, as well as the 
likelihood of the presence of degradation 
products and/or stabilizing antioxidant agents 
for vitamin C, HPLC method possesses 
advantages. HPLC is considered a sensitive 
and selective method and therefore suitable 
for active substance determination; it is also 
suitable for the evaluation of stability in 
formulations in the pharmaceutical and 
cosmetic industries [14].  
 
The purpose of this study, therefore, was to 
develop and validate a HPLC method for the 
quantitation of vitamin C (ascorbic acid) in 
pharmaceutical powder or tablet preparations 





HPLC apparatus and conditions 
 
The HPLC system used consisted of a 
Hewlet Packard  HPLC 1100 Series isocratic 
LC system with diode array detector (DAD) 
and flame-photometric detector (FLD). Prior 
to performing the validation assay, 
chromatographic conditions for the HPLC 
method were studied in order to achieve 
appropriate system suitability. Mobile phase 
composition was tested with methanol 
/phosphate buffer + tetrabutylammonium 
(30:70 and 70:30, v/v) in C8 column (λ = 254 
nm); and 0.2 % metaphosphoric acid in water 
solution, 0.2% metaphosphoric acid/methanol 
(95:5 and 90:10, v/v), 0.2% metaphosphoric 
acid /acetonitrile (95:5 and 90:10, v/v) and 
0.2% metaphosphoric acid/methanol 
/acetonitrile (90:5:5, v/v/v) in C18 column (λ = 
254 nm).  
 
The column used was Superspher RP-18 
(250 x 4.6mm) while the mobile phase (pH 
2.6) consisted of 1.5 g dissolved in 500 ml of 
acetic acid (99,8%) and mixed well. Routine 
degassing of the mobile phase was carried 
out by passing it through a 0.45 µm 
membrane filter (Millipore, Bedford, MA, 
USA). The mobile phase was pumped 





C. This low operating temperature was 
used because the stability of ascorbic acid 
decreases with increasing temperature The 
injection volume was 50 µL. 
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Reagents and chemicals 
 
Ascorbic acid (C6H8O6) with 99.0% purity was 
kindly provided by F. Hoffmann–La Roche 
Ltd. Basel, Swiss..  Doxycycline was obtained 
from PromoChem, Teddington, United 
Kingdom. All the solvents used were of HPLC 
grade while the other chemicals were of 
spectroscopic grade and obtained from 
Merck (Darmstadt, Germany). Pure water 
was produced with a Millipore Milli-Q Plus 
System (Molsheim, France). All the reagents 
were used without any further purification. 
Branded pharmaceutical and veterinary 
formulations, in powder or tablet form, were 
obtained from commercial sources and used 
as received, without any further purification. 
The composition of the preparations are as 
follows: 
 
Vetadox powder: Supplied by “Actavis” 
Leskovac, Serbia, it consists of various 
ingredients, among them doxycycline hyclate 
(the only active component; content, 250 
mg), vitamin C (50 mg) as anti-oxidant and 
glucose as sweetner. 
 
Ferveks for adults (Bristol-Myer Squibb-
New York, USA in powder form and 
contained pheniramin  (25 mg), paracetamol 
(500 mg), vitamin C (200 mg) and flavor 
(25mg) 
 
Eferalgan (Bristol-Myer Squibb, New York, 
USA), an effervescent tablet, contained  
paracetamol (330 mg), vitamin C (200 mg), 
and KHCO3, NaHCO3, sorbitol, citric acid 
anhydride, sodium-benzoate, sodium 
docusate and povidone as excipients.  
 
Ca+C-vitamin (Innopharm, Budapest, 
Hungary), an effervescent tablet, contained  
Ca (300 mg, 37.5 %) in the form of calcium 
carbonate, vitamin C (60 mg), as well as 
CaCO3, NaHCO3, sorbitol, citric acid 
anhydride, Na-cyclamate, Na-saccharin , 





Approximately 50 mg of standard ascorbic 
acid (99 % purity) was weighed precisely and 
dissolved in 50 mL of water-acetic acid clear 
mixture (20:1, v/v) to obtain a stock 
concentration of 1 mgmL
−1
. Standards were 
freshly prepared. To obtain the working 
solution, aliquots of standard ascorbic acid 
solution were diluted to a concentration of 0.2 
mg ml 
-1
. The working standard solutions 
were prepared in duplicate, filtered and 
degassed by passing them through a 0.45 
µm membrane filter (Millipore, Bedford, MA, 
USA). The linearity study verifies that the 
sample solutions are in a concentration range 
where analyte response is linearly 
proportional to the concentration. To 
establish linearity of the proposed methods, 
five separate series of ascorbic acid solutions 
were prepared from the stock solutions and 
analyzed. Least square regression analysis 
was done for the data obtained. The linearity 
was studied over a concentration range of 
0.15 – 0.25 mg mL
-1
. Replicates of three 
injections were performed for each sample. 
Linearity data were computed on a personal 
computer using Microsoft Excel program 
(version 2003, Microsoft Co., Redmond, 
USA). 
 
Accuracy/recovery and precision assay 
 
The accuracy of the method is the closeness 
of the measured value to the true value for 
the sample. Accuracy was assessed as 
percent relative error and mean % recovery. 
 
Approximately 40, 50 and 60 mg of standard 
ascorbic acid were weighed precisely and 
dissolved, separately, in 50mL of the mobile 
phase. To achieve accuracy/recovery, 
aliquots of these samples were diluted to 
appropriate final concentrations of ascorbic 
acid solution [15], i.e., 2 ml of each solution 
diluted to 10 ml with mobile phase solution. 
The accuracy of the method was checked by 
determining recovery values. Accuracy/ 
recovery was calculated for six runs of each 
solution. 
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The precision was determined by measuring 
five sample probes under the same 
experimental conditions. To calculate 
precision, intra- and inter-day tests were 
performed and the results were expressed as 
relative standard deviation (RSD, %).  
 
Limits of detection (LOD) and quantitation 
(LOQ) assay  
 
The limits of detection and quantitation were 
determined by serial dilutions of ascorbic acid 
solutions in order to obtain signal/noise ratios 
of ≈ 3:1 for LOD and ≈ 10:1 for LOQ. 
 
Approximately 25 mg of standard ascorbic 
acid was weighed precisely and dissolved in 
50 mL of the mobile phase. Appropriate 
amounts of standard ascorbic acid solution 
were diluted to the required concentrations of 
0.5, 1.0, 1.5 and 2 µg mL
−1
. Working 




The specificity of the HPLC method for 
ascorbic acid quantitation in pharmaceutical/ 
veterinary preparations was investigated in 
order to obtain an indication of possible 
interference from excipients in topical 
preparations. 
 
For specificity and selectivity of method, 
ascorbic acid solutions (0.2 µg ml
-1
) were 
prepared in the mobile phase along with and 
without common ingredients (doxycycline 
hyclate, pheniramin, paracetamol, CaCO3, 
KHCO3, NaHCO3, sorbitol, citric acid 
anhydride, sodium-benzoate, sodium 
docusate, povidone, Na-cyclamate, Na-
saccharin, synthetic beta carotene) 
separately. All the solutions were injected into 
the Superspher RP-18 (250 x 4.6mm) 
column. In this assay, it was tested by 
running solutions containing placebo (using 
the same quantities and conditions as for the 
test samples) to verify that there is no 
overlapping peak at the retention times 
corresponding to those of the analytes. 
Paired t-test at 95 % level of significance was 




Approximately 250 mg of each topical 
formulation was weighed precisely and 
dissolved separately in 50 mL of the mobile 
phase. The mixtures were centrifuged at 
3000 rpm for 5 min at room temperature (20 
0
C). The supernatants were collected and 
aliquots of the samples were diluted to 








The mobile phase (pH 2.6) prepared by 
carefully adding acetic acid (500 mL) to 1.5 g 
of 1-hexanesulfonic acid sodium salt 
thorough mixing gave good response and a 
retention time of 4 min for ascorbic acid. The 
other mobile phases tested did not present 
adequate response for ascorbic acid 
quantitation since they were not able to 
identify the antibiotic, doxycycline, as a 
component of the  pharmaceutical 
preparations, and also provided unsuitable 
retention time for the active substance (≈ 1 




The linearity was checked on samples of 
standard ascorbic acid at five different 
concentrations (0.25 – 1.5 mg mL
−1
). The 
regression equation derived was: y = 10245x 
– 89.95 with a correlation coefficient (R
2
) of 
0.9998, where x represents concentration in 
µg ml−
1
, and y represents the HPLC peak 
area, which was automatically measured by 
an integrator of the HPLC instrument. 
Linearity data were computed on a personal 
computer using Microsoft Excel program 
(version 2003, Microsoft Corp., Redmond, 
USA). 
 
Accuracy/recovery and precision  
 
Accuracy/recovery was calculated for three 
runs of each solution.  The results of 
accuracy/recovery and precision experiments 
Mitić et al 
Trop J Pharm Res, February 2011;10 (1): 109 
are recorded in Table 1. The data indicate an 
adequate percentage of accuracy/recovery 
for the HPLC method for the quantitation of 
ascorbic acid in the pharmaceutical 
preparations [17,18].  
 
Table 1:  Accuracy of the HPLC method for 






y (%)  
X 
X ±SD RSD (%) 
40 102.43 102.39±0.049 0.048 
 102.42   
 102.34   
50 102.03 101.70±0.450 0.442 
 101.89   
 101.19   
60 100.09 100.07±0.020 0.020 
 100.05   
 100.07   
 
 
Limits of detection (LOD) and quantitation 
(LOQ) 
 
 LOD, which is defined as the lowest active 
substance concentration that can be 
determined by a method, usually cannot be 
calculated precisely and accurately. On the 
other hand, LOQ is the concentration of the 
sample used in analysis that can be obtained 
with adequate precision and accuracy. An 
estimation of the limits, which was achieved 
by the determination of the signal/noise ratios 
of 3:1 (LOD) and 10:1 (LOQ), were ≈ 1.95 
and ≈ 6.5 µgmL
−1





The specificity of the HPLC method for 
vitamin C quantitation in the pharmaceutical 
formulations is an indication of possible 
interference from excipients in the 
preparations. The presence of other 
ingredients, including the antibiotics, in the 
formulations did not cause any interference 
with the ascorbic acid peak. Under the test 
conditions, ascorbic acid was observed to be 
well resolved from the other components of 
the formulations and potential degradation 
products of vitamin C. Thus the method is 
specific for vitamin C. 
 
Application of the developed method to 
vitamin C formulations 
 
The outcome of the application of the 
developed method to the determination of 
vitamin C in some pharmaceutical 
formulations are shown in Figures 1 and 2. 
The representative chromatograms of the 
standard sample of vitamin C and the test 
preparations show identical retention times. 
 
 
Fig 1: Representative chromatograms of (a) 
standard vitamin C, (b) Vetadox powder and (c) 
Ferveks powder  
 
Fig 2: Representative chromatograms of (a) 
standard vitamin C, (b) Eferalgan powder, (c) Ca-
C-vitamin powder 
  
Assay results for the determination of 
ascorbic acid in commercial pharmaceutical 
are shown in Table 3. RSD (%) indicates the 
accuracy of determination of ascorbic acid in 
the investigated pharmaceutical preparations  
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Table 3: Assay results for the determination 
of ascorbic acid in some commercial 











Vetadox 50 49.52 ± 
0.93 
1.87 
Ferveks 200 190.05 
± 3.32 
1.36 














The mobile phase used increased retention 
time to ≈3.5 min, providing a satisfactory 
resolution of ascorbic acid from doxycycline 
and the excipients present in the 
formulations, with sharp and symmetrical 
peaks, and also minimal interferences from 
equipment noise. In addition, the mobile 
phase maintained long column life. 
The results demonstrated satisfactory and 
consistent performance of the HPLC method. 
Least-squares regression analysis used to 
evaluate the concentration range data 
indicate excellent linearity over the interval 





for this ascorbic acid concentration range 
was ≥ 0.99.  
The low values of RSD (0.38 and 1.22 %, 
respectively) are evidence of the good 
precision of the developed HPLC method and 
also indicates non-variability of the data. LOD 
and LOQ values of ≈1.95 and ≈6.5 µg mL
−1
, 
respectively, indicate that the method is 
sensitive.  
 
The presence of the other ingredients in the 
formulations, including an antibiotic 
(doxycycline) did not cause any interference 
with ascorbic acid peak. Ascorbic acid was 
well resolved from the other components of 
the formulations and the potential degra-
dation product of vitamin C. Thus, the method 
is selective for vitamin C. 
 
The relative standard deviation (RSD) of 1.87 
% was low, being less than < RSDmax. Thus 
the  method is precise. Overall, the results 
show that the proposed method can be 
successfully applied for the determination of 
vitamin C in pharmaceutical preparations.  
 
CONCLUSION 
The developed HPLC method for the 
determination of ascorbic acid in 
pharmaceutical preparations containing 
various other ingredients including excipients 
(doxycycline hydrochloride, pheniramin, 
paracetamol, etc) has been validated for 
linearity, sufficient accuracy/recovery and 
precision, as well as low values of limits of 
detection and quantitation. The method 
provides a rapid, sensitive, accurate, and 
reproducible means of determining vitamin C 
in pharmaceutical and veterinary formulations 
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